Development of the G3 designed ankyrin repeat protein (DARPin) for HER2 imaging
Background: Human epidermal growth factor receptor-2 (HER2) expression predicts response to anti-HER2 therapy in breast and gastric cancer. HER2 status is assessed by tumour biopsy but this may not be representative of the larger tumour mass or other metastatic sites; risking misclassification and s...
| Main Author: | |
|---|---|
| Published: |
University College London (University of London)
2015
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.647218 |